Table 1 Background of subjects
Age(y) | |
|---|---|
Means ± SD | 8.62 ± 2.46 |
Median | 8 |
Maximum | 14 |
Minimum | 4 |
Sex | |
Male | 38 (76.0%) |
Female | 12 (24.0%) |
Gender comparison by age group | |
4–6 y (n = 9) | |
Male | 6 (66.7%) |
Female | 3 (33.3%) |
7–14 y (n = 41) | |
Male | 32 (78.0%) |
Female | 9 (22.0%) |
Druga | |
Guanfacine Hydrochloride | 25 (50.0%) |
Methylphenidate Hydrochloride | 18 (36.0%) |
Risperidone | 12 (24.0%) |
Aripiprazole | 11 (22.0%) |
Atomoxetine Hydrochloride | 9 (18.0%) |
Ramelteon | 2 (4%) |
Hangekobokuto (Kampo medicine) | 2 (4%) |
Yokukansan (Kampo medicine) | 2 (4%) |
Yokukansankachimpihange (Kampo medicine) | 1 (2%) |
Sertraline Hydrochloride | 1 (2%) |
Sodium Valproate | 1 (2%) |